护士和助产士对危险药物的处理:一个回顾性队列研究
Pheona van Huizen1, Paul Wembridge2, Philip L Russo3
1Monash Nursing and Midwifery, Monash University, Australia.
International journal of nursing studies
|September 21, 2024
概括
医疗保健工作者面临危险药物的职业暴露风险,这些药物在各种环境中使用,而不仅仅是癌症服务. 这项研究强调了这些药物的广泛存在以及护士和助产士暴露的可能性.
科学领域:
- 职业健康 职业健康 职业健康
- 临床药房 临床药房
- 护理实践 护理实践
背景情况:
- 医疗保健工作者面临职业接触危险药物的风险,这些药物对健康构成严重风险,包括致癌性和器官毒性.
- 之前关于职业接触危险药物的研究主要集中在癌症服务上,可能会忽视其他领域的风险.
研究的目的:
- 确定护士和助产士管理危险药物的特定医疗保健机构.
- 评估各种临床环境中护士和助产士处理危险药物的职业暴露风险程度.
主要方法:
- 一项回顾性队列研究分析了大都市卫生服务中心两周内的药物管理事件.
- 来自六家医院的电子和纸质记录被审查以确定危险的药物管理事件.
- 普森回归模型被用来分析危险药物管理和医疗保健领域之间的关联.
主要成果:
- 在121567例药物管理事件中,约有5.0%涉及危险药物.
- 门诊癌症服务 (43.3%),分娩室 (15.1%) 和心理健康部门 (10.1%) 显示了危险药物管理的最高率.
- 医疗和老年患者住院区域记录了最多的危险药物管理事件,口服剂型是最常见的 (89.6%).
结论:
- 危险的药物几乎在所有医疗保健机构中都被使用,这挑战了以前仅专注于癌症服务的做法.
- 在广泛的临床领域,护士和助产士经常接触危险药物,这表明职业风险很大.
- 这些发现强调,需要在所有医疗保健机构中制定全面的安全协议,以处理危险药物.
关键词:
行政管理 行政管理 行政管理危险的药物 危险的药物危险的药物 危险的药物医疗保健 医疗保健 医疗保健 医疗保健药物治疗管理 药物治疗管理药品 药品 药品 药品 药品助产士 助产士 助产士 在护士是一个护士.职业暴露 职业暴露更多相关视频
相关概念视频
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
Guidelines and Strategies for Safe Computer Charting
798
The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:
Maintain Confidentiality and Security:
798
Pharmacovigilance
786
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
786
Healthcare Associated Infections II: Preventive Measures
2.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Hazard Ratio
92
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
92


